Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Omiganan Gel in Rosacea
NCT02576847Phase 3Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Oct 2015
- Primary completion
- Jul 2017
- Countries
- 8
01
Overview
Phase 3, open-label, single-arm trial of CLS001 topical gel vehicle in papulopustular rosacea, sponsored by Maruho Co., Ltd. Primary endpoint: Number of Subjects With 1 or More Treatment-related Treatment-Emergent Adverse Events at 12 months. Started Oct 2015; status: completed.
02
Drugs
CLS001 topical gel vehicle
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT02576847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02576847.